Heatwaves are threatening Europe’s power supplies, researchers warn
An international team of researchers have shown how heatwaves impact European countries’ ability to generate and supply power, and how they pose an increasing threat to vital national infrastructure.
The team, from the University of Cambridge, City University of Hong Kong, and The Chinese University of Hong Kong (Shenzhen), have developed the first open-source toolkit to help national operators understand the different ways that high heat affects their power grid.
According to the researchers’ model simulations, France, Spain and Italy are at highest risk of supply bottlenecks and possible grid failure. Germany and the UK were comparatively more resilient, although the researchers say that the increasing frequency and severity of heatwaves also place their grids at risk of failure, especially after Earth has just experienced its hottest August on record.
“We hope power providers will use these tools to identify vulnerabilities in their systems and take necessary action to stop them collapsing during future heatwaves,” said co-corresponding author Professor Srinivasan Keshav from Cambridge’s Department of Computer Science and Technology.
The results, reported in the journal Nature Energy, are based on a long-term study of the heatwaves of 2019, 2022 and 2024. The researchers used these in their exploration of the interlinked ways that heatwaves put strain on electricity grids.
Heatwaves increase demand for cooling, leading to spikes in electricity consumption. Meanwhile, total power supply falls because, as heat rises, solar panels lose efficiency, and both conventional and nuclear output are cut to prevent overheating. The same high pressure patterns that bring hot weather often also bring low winds, causing wind farms to falter, which further exacerbates the problem.
Power lines, too, must have their load reduced to stop them hitting their heat limits, and are at higher risk of breaking as they sag in the heat. When taken together, these connected issues can lead to supply bottlenecks and what is called load shedding: intentional power cuts to reduce demand and protect power systems.
While these are known problems, the researchers say that conventional models and analyses to date have revealed only parts of the problem and only at a high computational cost. So, they developed their own algorithms to try and capture the full picture of what is going on with a lower computational burden.
“Once you combine all the factors together — demand increase, generator capacity decrease, transmission capacity decrease — you can discover hidden bottleneck regions that existing methods can't find. I think that's the most surprising outcome of our simulations,” said lead author Professor Enming Liang from City University of Hong Kong.
The researchers applied their model to Western European electricity grids under projected future heatwave scenarios and represented grid configurations. They focused on eight countries (Spain, Portugal, France, Italy, Germany, Belgium, the Netherlands, and the UK) that have all been impacted by recent historic heat waves.
When they looked at the results produced by their model, they found significant differences across countries. In France, Spain and Italy, they saw that heatwaves would lead to a greater risk of supply bottlenecks and load shedding.
However, it was a different story in Germany and UK, where analysis revealed that power systems remained comparatively resilient, although these too showed a rising risk of failure as heatwaves intensify and demand peaks.
The researchers say that their findings assume only a conservative annual increase in demand over the next five years and do not include the emerging boom in datacentre construction. They also assume existing storage capacity is fully charged when a heatwave arrives, which may not always be the case.
“Even under that ideal assumption, existing storage resources are still insufficient to prevent load shedding,” said co-corresponding author Professor Minghua Chen, from the Chinese University of Hong Kong (Shenzhen) and City University of Hong Kong. “I think that’s a genuinely alarming, surprising finding from this research.”
The researchers make several recommendations to help operators heat-proof their grids, including building energy storage capacity near high demand locations, upgrading existing transmission lines to carry more power at higher temperatures, and even applying a cooling, reflective coating to powerlines.
They also considered whether countries could look to their neighbours for back-up power during a heatwave but found that while it works in some cases, it’s not always a reliable strategy.
The value of cross-border support depends on whether neighbouring systems have surplus capacity under the same heat stress and whether there is available surplus capacity in neighbouring systems, and sufficient transmission infrastructure to deliver power where needed.
The researchers are making their data sets, algorithms and source code available as a downloadable toolkit called HEAT-Analysis that they hope will provide actionable insights for near-term resilience planning and investment decisions. Operators simply plug in proprietary data about their country’s infrastructure, and the tool reveals vulnerabilities and lets them test different solutions.
“I’d say it represents a paradigm shift for European grid operators,” said Chen. “They should really be using heatwave or summer-peak conditions in their planning and stress-testing, alongside traditional winter peaking. I hope our work is raising people’s attention to that.”
They caution that there are inevitable limitations on their work, such as uncertainties about climate and demand projections, and the limited resolution of publicly available grid data.
But they say that even with these limitations, their tool identifies where, to what extent, and through which coupled physical mechanisms, heatwaves create operational stress under the represented grid infrastructure.
Reference:
Enming Liang, Minghua Chen & Srinivasan Keshav. ‘Heatwave-induced capacity bottlenecks in European electricity grids.’ Nature Energy (2026). DOI: 10.1038/s41560-026-02151-1
From awareness to action: launching Embers of Hope: Science Behind the Series as COP31 begins
As world leaders, negotiators, scientists and civil society organisations gather in Turkey for COP31, attention is once again focused on one of the defining challenges of our time: how to respond to accelerating environmental change while building a more sustainable and equitable future.
International agreements and national policies matter, and these are the focus of the discussions in Antalya. But lasting change also depends on something more fundamental: helping people understand environmental challenges, and to recognise their own capacity and agency to contribute to solutions.
Today, the University of Cambridge's Department of Geography is launching Embers of Hope: Science Behind the Series, a free educational website that explores some of the most important environmental challenges facing India and the world through a combination of scientific evidence, documentary storytelling and practical examples of change.
The resource accompanies the documentary series Embers of Hope: The Fight for Our Future, co-anchored by Bhaskar Vira and Zeenat Aman, produced by Robin Roy Films for Warner Bros. Discovery, India, and conceived, produced and generously supported by the Mobius Foundation.
Now freely available online, the documentary and accompanying educational materials aim to support educators, students, researchers and engaged citizens seeking to better understand environmental change and the pathways towards more sustainable futures.
Bringing environmental science to wider audiences
India sits at the heart of many global environmental debates. As a major economy, a global centre of innovation and home to more than a billion people, the choices made across the Indian subcontinent will play an important role in shaping planetary futures. The documentary series explores these issues through the lens of Indian experiences, communities and solutions.
Across ten episodes filmed at locations throughout India and beyond, Embers of Hope examines the science and human realities behind environmental change, while highlighting individuals and communities working to build more resilient and sustainable futures. The complete documentary series can be viewed free of charge via the Mobius Foundation's YouTube channel.
The series asks difficult questions about environmental degradation, but it also looks for answers, focusing on local, community and national responses, highlighting both the challenges and the opportunities for action.
Educational platform
The new educational platform is organised around seven major environmental themes explored in the series: climate change, biodiversity loss, air pollution, agriculture, freshwater, oceans and coasts, and population and urbanisation.
Each theme includes accessible educational content designed to help users explore the science behind environmental change, understand its societal implications, and learn more about possible responses. The site also includes curated resource packs featuring academic research, articles, videos, visualisations and case studies.
Rather than presenting environmental challenges as isolated issues, the resources emphasise the connections between ecological systems, human wellbeing, development and social justice.
Beyond awareness, to agency
One of the distinctive features of Embers of Hope is its focus on agency.
Environmental communication often struggles between two extremes. On the one hand, there is a temptation to minimise environmental risks. On the other, there are narratives that can leave audiences feeling overwhelmed by the scale of the challenge.
The documentary and associated resources seek a different approach.
Throughout the series, scientific evidence is paired with stories of people making a difference: communities restoring ecosystems, innovators developing solutions, educators inspiring learners and citizens working collectively to address environmental challenges.
The aim is not simply to increase awareness, but to support environmental literacy while encouraging informed participation and practical action.
A resource for educators
The launch is also a significant contribution to sustainability education, which remains a core theme for COP31.
The educational materials have been designed to be freely accessible and usable by schools, universities, community groups and independent learners. By bringing together documentary storytelling and scientific resources, the resource provides educators with new ways to engage learners with complex environmental issues.
At a time when Cambridge is supporting educators around the world in considerations about how best to teach sustainability, climate change and environmental responsibility, these resources are designed to help learners move beyond understanding environmental problems towards engaging with possible solutions.
Explore the resources: Embers of Hope: Science Behind the Series.
Watch the documentary series: available free online via the Mobius Foundation's YouTube playlist.
series of photos from embers of hope Yes‘Fossil record’ in stored blood samples lets scientists trace leukaemia back decades before diagnosis
The discovery could help predict whether an individual will develop the disease years – or even decades – before symptoms arise, raising the possibility of preventing the disease before it develops.
In research published today in Nature, a team at the University of Cambridge and University College London (UCL) used blood samples collected annually, some dating back 15 years before diagnosis, as a ‘fossil record’ of the disease's development, tracing it step by step. Using ultra-sensitive DNA sequencing and mathematical modelling, they estimated when each mutation arose and how quickly the affected cells multiplied and competed with other blood cells in the years prior to AML diagnosis.
AML is an aggressive blood cancer affecting around 2,700 people in the UK each year. Only around one in six survive five years after diagnosis. Many healthy older people carry blood cells with mutations also found in leukaemia, a condition known as clonal haematopoiesis, but only a small proportion develop AML. What has not been clear is why, because the process has never been tracked year by year in the run-up to diagnosis.
The researchers used samples from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), in which around 50,000 women gave a blood sample every year for up to 11 years. The team studied 47 women who later developed AML, at an average age of 72, alongside matched samples from 46 women who stayed blood cancer-free.
This first mutation, acquired before age 20 in two-thirds of the women who developed AML, was followed by decades of slow growth – cells carrying it took years to double in number. Each additional mutation increased their growth rate around two- to three-fold, with cells carrying four cancer-driving mutations doubling in a matter of weeks.
The growth of these groups of cells, known as clones, proved remarkably predictable. Once a clone carrying a cancer-driving mutation was established, it expanded at a steady rate, slowing only when it ran out of room or was overtaken by a faster-growing clone. In practice, this means a clone's growth rate, measured from a few blood samples today, can be used to estimate how large that clone may become years and even decades into the future.
In at least a third of the AML cases, a clone had come to dominate the blood years before diagnosis, a phenomenon known as a ‘somatic sweep’. No such sweeps were seen in the women who remained blood cancer-free. The team confirmed the link with AML risk using UK Biobank data, finding that people with these sweeps were at greatly increased risk of developing the disease. The findings highlight the importance of recognising this potential warning sign, which standard genetic analysis often overlooks by mistaking these mutations for inherited variants.
Professor Jamie Blundell from the Early Cancer Institute at the University of Cambridge, who led the study, said: “Serial blood samples are a fossil record of the blood's evolution. They let us go back in time and reconstruct when each mutation arose and how fast it grew. What surprised us most is how predictable the growth of these clones is. Once a clone is established, its growth rate today tells you where it will be years, even decades, from now.”
He added: “Because the growth is exponential, even modestly slowing a high-risk clone over the decade or more before diagnosis could substantially reduce the chance it becomes leukaemia. This opens up strategies we can exploit to prevent these clones ever becoming leukaemia.”
Dr Caroline Watson, also from the Early Cancer Institute, and first author of the study, said: “As a haematologist, I've seen how suddenly AML can change someone's life. This study shows that the changes leading to AML can build over decades, with the affected cells growing in surprisingly predictable ways.”
Dr Watson is also an Honorary Consultant Haematologist and sees patients at the Cambridge Clonal Haematopoiesis Clinic at Addenbrooke’s Hospital, the first clinic focusing on leukaemia prevention in Europe. She added: “At our clinic, we already assess and monitor people who carry blood-cell mutations that increase their risk of leukaemia. Today’s findings give us real hope of improving how we identify which of them are at greatest risk and point to a window in which prevention could one day be possible.”
Professor Usha Menon, from the UCL Institute of Clinical Trials and Methodology, who led UKCTOCS, said: “While UKCTOCS was designed to assess ovarian cancer screening, a key outcome was the establishment of a unique bioresource of serial serum samples. This resource has provided unprecedented opportunities to study how cancers develop over time and to discover and validate biomarkers for earlier detection. We owe an enormous debt of gratitude to the participants whose willingness to contribute their samples and data over many years made this possible. Their generosity is the foundation of this achievement.”
The women were diagnosed with AML between the ages of 53 and 83, and the study did not include samples taken at time of diagnosis. In around one in five cases, expanding populations of mutated cells were not detectable until one to two years before AML diagnosis, suggesting that some cases may offer a shorter warning period.
The findings point towards opportunities for early detection and prevention. The team's modelling suggests that even a small reduction in a clone's growth rate, compounded over the ten or more years between the second mutation and diagnosis, could substantially reduce the risk of progression to leukaemia. This raises the possibility of preventative treatments that slow these cells' growth before leukaemia develops. Testing whether this can be achieved safely and effectively in people identified as high risk is the team's next step.
The research was largely funded by UK Research & Innovation and Cancer Research UK.
The University of Cambridge and Addenbrooke's Charity are fundraising for Cambridge Cancer Research Hospital, which will include the Early Cancer Institute Research Clinic, where detecting cancer at its earliest stages will be a key goal. Set to be built on the Cambridge Biomedical Campus, the hospital will bring together clinical excellence from Addenbrooke’s Hospital and world-leading researchers at the University of Cambridge. The research that takes place there promises to change the lives of cancer patients across the UK and beyond. Find out more here.
Reference
Watson, CJ, et al. Evolutionary dynamics in the years preceding acute myeloid leukaemia. Nature; 11 Nov 2026; DOI: 10.1038/s41586-026-11269-x
Serial blood samples are a fossil record of the blood's evolution. They let us go back in time and reconstruct when each mutation arose and how fast it grew Jamie Blundell NEMES LASZLO/SCIENCE PHOTO LIBRARY (Getty Images) Acute myeloid leukaemia - illustration YesOver 9 million lives could be saved every year if countries met WHO air quality guidelines
It would also bring substantial savings from reduced illness, including lower healthcare costs and increased productivity as individuals take less time off work resulting from preventable illness.
Outdoor air pollution is the largest environmental threat to human health worldwide. It has been linked to increases in heart and lung diseases, including coronary heart disease, stroke, asthma, chronic obstructive pulmonary disease, and dementia. As well as the burden on individuals and their families, these diseases also have a substantial economic toll in terms of healthcare costs and lost productivity.
Because of the growing body of evidence of the impact of poor air quality, in 2021 the World Health Organization (WHO) revised its air quality guideline values for recommended maximum levels for several pollutants, including fine particulate matter (PM2.5) and nitrogen dioxide (NO2).
PM2.5 is particulate matter with a diameter of 2.5 microns or less, tiny particles small enough that they can be inhaled deep into the lungs. These particles come from several sources, including vehicle emissions, power plants, industrial processes, wood burning stoves and fireplaces, and construction dust. They also form in the atmosphere because of complex chemical reactions involving other pollutants such as sulphur dioxide and nitrogen oxides.
Nitrogen dioxide is one of the key pollutants that arise from burning fossil fuels. It is found in vehicle exhaust emissions, especially from diesel vehicles, and industrial emissions, as well as those from gas stoves and heaters.
The problem disproportionately affects low- and middle-income countries (LMICs), where air quality has generally deteriorated in line with large-scale urbanisation, economic development, and increasing use of cars and motor vehicles.
In a paper published today in Environment International, researchers at IMS Epidemiology, University of Cambridge, explored the potential health and economic benefits of improving air quality in 136 LMICs, focusing on PM2.5 and NO2.
The team combined detailed data from air pollution, population size and health with published evidence on the links between pollution, mortality and disease. They used computer modelling to estimate how deaths and new cases of illnesses might change if levels of particular pollutants fell to the WHO’s recommended air quality guidelines values and the more relaxed WHO interim targets. They also estimated the economic value of reducing the risk of premature death, alongside potential savings in healthcare and productivity costs.
The results suggest that meeting the WHO’s guideline levels for PM2.5 could prevent or postpone an estimated 9.4 million deaths in a single year across the countries studied. Reaching the guidelines for NO2 could prevent or postpone around 1.1 million deaths*.
Even meeting the less stringent interim targets could lead to substantial population health benefits: around 6.6 million fewer deaths associated with PM2.5 and 435,000 associated with NO2.
The potential benefits extend beyond reducing deaths. The researchers estimated that meeting the recommended PM2.5 levels, could mean 2.8 million fewer new cases of chronic obstructive pulmonary disease, 1.1 million fewer new cases of dementia, 7.3 million fewer new cases of coronary heart disease, and 2.3 million fewer new cases of stroke in a year.
Dr Annalan Navaratnam, Clinical Research Fellow at IMS Epidemiology, University of Cambridge, said: “Tackling air pollution is likely to have a huge impact on improving quality of life and reducing the number of early deaths. For the first time, we’ve been able to model the potential benefits of the WHO’s clean air guidelines across countries with the highest levels of outdoor air pollution, both in terms of the millions of lives that could be saved every year and the potential economic and societal benefits.”
The team showed that there could also be substantial economic benefits, including savings from reduced healthcare spending and productivity losses. For example, meeting the PM2.5 guidelines could lead to annual direct medical cost savings estimated at $11.8 billion for coronary heart disease, $5.9 billion for stroke, and $8.6 billion for dementia.
By preventing illness and disability, cleaner air would reduce lost work capacity. The PM2.5 WHO guidelines could lead to estimated annual productivity gains including $17.9 billion for stroke, $18.1 billion for COPD and $5.3 billion for coronary heart disease.
Dr Haneen Khreis, also from IMS Epidemiology, Cambridge, added: “Meeting the WHO’s air quality guideline values will not be straightforward, but low- and middle-income countries have a critical opportunity to shape healthier futures as their populations grow and their cities expand.
“Decisions about transport, urban planning and energy can make a real difference to the air people breathe and the diseases they experience. Economic development is essential for these countries, but it need not come at the expense of public health. Having a healthy population is not just a moral imperative; it will almost certainly bring large economic benefits.”
The research was supported by UK Research & Innovation (UKRI).
Reference
Navaratnam, AMD, et al. Health and Economic Impacts of Achieving WHO Air Quality Targets in 136 Low- and Middle-Income Countries. Environment International; 10 Nov 2026; DOI: 10.1016/j.envint.2026.110577
Meeting the WHO’s air quality guideline values will not be straightforward, but low- and middle-income countries have a critical opportunity to shape healthier futures as their populations grow and their cities expand Haneen Khreis Photoholgic (Unsplash) Aerial view of high-rise buildings covered with smoke Yes Licence type Public DomainCambridge Enterprise opens new hub South Korea
Leaps, a Cambridge Enterprise initiative, is creating a bridge between Cambridge and key innovation hotspots around the world. The initiative will give selected Cambridge Enterprise portfolio companies access to new markets, talent and investment, opening the pathways for deep collaborations in these settings. With eleven companies already joining the initiative, Seoul-Incheon is the third landing spot chosen by Cambridge Enterprise.
Working with Yonsei Science Park and iCREATE, Seoul-Incheon joins London and New York as part of the Leaps programme. This new partnership will open the door to major strategic partners such as Samsung, SK, Hyundai or LG for Cambridge companies.
Jim Glasheen, Cambridge Enterprise Chief Executive said: “Bringing Cambridge innovations to the heart of South Korea’s tech hub will undoubtedly help foster new collaborations between two vibrant ecosystems. Exposure to new ecosystems is essential for the healthy growth of startups. In London, New York and Seoul, our partners in each location will act as bridges, enabling the companies to become a ‘local’ within these ecosystems, creating the meaningful connections that will allow these companies to succeed.”
Raphael Peralta, CEO and Co-founder of Cambridge spinout CardiaTec Bio, the first company participating in the Seoul-Incheon Leap, said: "Joining the Seoul-Incheon Leap gives CardiaTec a base in one of the world's fastest-growing biopharma ecosystems. Being based in Songdo, alongside Yonsei and Korea's leading pharmaceutical companies, hospitals and investors, will help us build partnerships to develop large-scale human heart tissue multiomics datasets, paired with real-world healthcare data, to drive the next generation of cardiovascular therapies that can transform patients' lives."
For South Korean companies, it will mean transformative global opportunities, especially for spinouts and ventures originating from Yonsei University. They will be able to participate in Cambridge’s tech cluster, as part of the supportive ecosystem at St John’s Innovation Centre.
Jae-Ho Cheong, Senior Vice President, Office of Yonsei Science Park Project/Dean, Institute for Convergence Research and Education in Advanced Technology, (iCREATE), said: “Beyond simply hosting Cambridge companies, this launch is highly significant as it establishes a vital bridgehead for Yonsei startups and researchers to directly receive practical technology commercialisation and investment support in Cambridge—including workspace, local VC investor relations, one to one tailored mentoring and global industry-academic-research networking.”
"We will build a successful open-innovation model where the outstanding research achievements of both nations lead directly to global market expansion and investment attraction.”
With Cambridge ranked as one of the world’s top cities for innovation output per capita, the deep connections with London, New York and Seoul look to scale its impact though connection with powerful partners. The aim is to boost Cambridge-born companies by nurturing these international collaborations and help translate research from the University of Cambridge into practical applications.
In London, the companies participating are biotech company Xterna, therapeutics company GastrobodyTx, health monitoring company auryx, flat optics company Phaseshift and Cosysense, which is focused on Physical AI automation.
In New York, they are life science tools company Verinnogen, brain cancer pioneer Streamtrix, neuroimmunology gene therapy company Aila Biotech, Senesys.Bio, which is targeting age-related diseases and integrated photonics company Wave Photonics. Seoul’s first participating venture is CardiaTec Bio.
Adapted from a news story published by Cambridge Enterprise.
Yes
Cambridge joins UK Quantum SuperConnector to accelerate commercial success of quantum research
A consortium of five of the UK’s top universities, including the University of Cambridge, has announced the launch of the UK Quantum SuperConnector, an initiative designed to bridge the gap between quantum research and commercial success.
The initiative will create a UK-wide community of entrepreneurs, investors, industry adopters and policymakers that will strengthen the vibrant quantum ecosystem across the UK.
The programme will help researchers across the country to accelerate the adoption of quantum technologies, attract investment and enable growth.
The five universities – Cambridge, Imperial College London, and the Universities of Bristol, Glasgow and Oxford – all have deep strengths in quantum research and commercialisation.
Cambridge’s contribution will draw on its track record in translating quantum research into commercial success through both startups and industrial collaboration, including Nu Quantum, Riverlane, and the University’s partnership with IonQ to establish the IonQ Quantum Innovation Centre, which was launched in October 2026 and will be the home of the most powerful quantum computer in the UK when it is installed next year.
Professor Ramana Nanda from Imperial Business School will serve as Director of the Quantum SuperConnector. Dr Aga Iwasiewicz-Wabnig, Director of the University of Cambridge’s Maxwell Centre, will serve as Co-Director.
“The UK’s long-standing strategic investment in quantum research, including through its National Quantum Technologies Programme (NQTP), already generates world-class science,” said Iwasiewicz-Wabnig. “We must now build up a matched capability to commercialise and deploy emerging quantum-enabled technologies, wherever in the UK the right ideas originate.”
“The UK Quantum SuperConnector will draw on the decade of expertise of the Maxwell Centre in taking research towards impact,” said Professor Mete Atatüre, Head of Cambridge’s Cavendish Laboratory. “We will also explore connections with the recently-launched IonQ Quantum Innovation Centre, enabling UK quantum innovators to supercharge their progress towards commercial deployment.”
By connecting regional strengths in quantum research, entrepreneurship and industry, the SuperConnector will help build stronger innovation clusters across the country and support the growth of globally significant companies in every region of the UK.
The SuperConnector will support the Government’s mission to re-industrialise the UK as an innovation-led, research-driven economy, and harness the UK’s exceptional higher education assets in support of this ambition.
A central aim of UK Quantum SuperConnector is to support the development of the skilled workforce required for commercial deployment of quantum applications in critical sectors including healthcare, finance, aerospace and defence.
The SuperConnector will focus on building the commercial skills and networks needed to translate quantum research into valuable commercial assets, including new quantum and quantum-enabled ventures, licensing opportunities, partnerships and collaborative R&D.
In Cambridge, this will include the creation of a dedicated quantum track within the Maxwell Centre’s impulse for tech innovators accelerator, capitalising on its convening and network strengths, as well as the launch of a UK-wide digital ecosystem platform.
“The UK has a unique opportunity to turn its world-leading quantum research into globally competitive companies that will create jobs and drive economic growth,” said Nanda. “The UK Quantum SuperConnector will help unlock that potential by accelerating the journey from breakthrough science to real-world impact, helping to create the next generation of entrepreneurs and world-leading quantum companies across the UK.”
The UK Quantum SuperConnector team are inviting the UK quantum community and beyond to get involved via their Expression of Interest form – including researchers, founders, investors, deep-tech companies, end-users and organisations in the sectors that quantum technologies could transform.
Adapted from an Imperial College London media release.
Fisher Studios IonQ quantum computer YesJason Beer KC appointed to conduct Part Two of Independent Review following the death of Professor Jason Arday
Jason Beer KC has been appointed to chair Part Two of the Independent Review established by the University of Cambridge following the death of Professor Jason Arday in August 2026.
Mr Beer is a leading barrister, specialising in public inquiries, inquests, corporate investigations, public and police law, and has represented a range of clients, including individuals, central government, regulators, public authorities, and corporations.
The University Council has agreed the Terms of Reference proposed by Mr Beer and confirmed the membership of an independent Panel which will support his work. The full Terms of Reference for Part Two of the Review are available here:
Document Independent review part II terms of reference
Part Two of the Review will investigate and report on the University's institutional policies, procedures, decision-making and oversight, and how these operated in practice during Professor Arday's recruitment, appointment and subsequent time at Cambridge. In particular, Part Two will address:
- The recruitment and appointment of Jason Arday as Professor of the Sociology of Education and the recruitment and appointment of professors through the Board of Elector process
- The induction, mentoring and support of and for Professor Arday and for professorial staff
- The University’s response to allegations of research and other misconduct in the case of Professor Arday and more generally
- The support and protection available to academics facing significant public and media scrutiny
- The University’s institutional arrangements for recognising and responding to race equality (including the experiences of Black academics), disability, neurodiversity and reasonable adjustments – including how these arrangements operated in relation to Professor Arday
Jason Beer KC said:
"I have been asked to undertake an independent, thorough and searching examination of the University's institutional arrangements, and the decisions made, in the case of Professor Arday. That is a weighty responsibility, and one which I approach with an open mind, without preconceptions and with a determination to reach conclusions on the basis of what – and only what - the evidence establishes.
"Part Two will examine some difficult and potentially uncomfortable questions. I will look not simply at what the University's policies and procedures required, but also at whether they were themselves reasonable; how they operated in practice; who was responsible for making decisions; what information was reasonably available to them; whether relevant concerns were recognised and properly addressed; and whether the University's various structures and functions worked together effectively – all in the case of Professor Arday, and more broadly.
"I hope that those who have relevant knowledge or experience will feel able to contribute to the Review. Their perspectives may be important in understanding not only what happened in Professor Arday's case, but whether there are wider institutional changes to be made. I will take seriously my responsibility to treat participants with sensitivity, to respect confidentiality and to ensure fairness to anyone whose actions may be examined.
"An independent review must be prepared to identify failings where the evidence supports them, but it must equally be prepared to say where arrangements and decisions were appropriate. Its conclusions must be based on evidence, not assumption or predetermination because of an existing attitude of mind. My intention is that this Review will be rigorous, candid and constructive, and that its findings and recommendations will provide a sound basis for any necessary changes.
"I recognise that no review can undo the tragedy of Professor Arday's death. I nevertheless hope that a careful, transparent and independent examination of these matters can contribute to understanding, accountability, the rebuilding of trust and the process of reconciliation."
Mr Beer will be supported by an independent Panel bringing together expertise in higher education leadership and governance, research integrity, equality and inclusion, and the experiences of Black academics.
The Panel members are:
- Professor Rachael Gooberman-Hill: Rachael Gooberman-Hill is Professor of Health and Anthropology at the University of Bristol, and also currently serves as Co-Chair of the UK Committee on Research Integrity. She is a research leader whose published interdisciplinary research primarily addresses health and healthcare. Professor Gooberman-Hill has experience working in matters relating to research integrity, ethics and governance. She has led a research institute, and has chaired and served on research funding panels, advisory committees and steering groups.
- Professor Rachel Brooks: Rachel Brooks is Professor of Higher Education and Fellow of Linacre College at the University of Oxford, and a former President of the British Sociological Association. She is currently co-editor of the ‘Research into Higher Education’ book series (published by Routledge and the Society for Research into Higher Education) and has been editor-in-chief of the British Journal of Sociology of Education and Sociology, and co-editor of Sociological Research Online. She has served on the governing bodies of the Society for Research into Higher Education and the Economic and Social Research Council, and as a member of the Education sub-panel for REF 2021 and REF 2029.
- Professor Bertha Ochieng: Bertha Ochieng is Professor of Integrated Health and Social Care at De Montfort University and Chair of the Black Leaders in Higher Education Network Steering Group. Her academic and research work focuses on improving health and social care through high-quality education and research that contributes to better outcomes for marginalised and socially disadvantaged populations across the lifespan. Black Leaders in Higher Education is a UK-wide network of senior academic and professional services leaders championing equity, representation and meaningful inclusion for Black staff and students, while amplifying Black expertise and leadership to influence structural change across higher education.
- Ms Margaret Ayers: Margaret Ayers began her career in people and organisational development in the retail sector and has held senior roles in five very different universities: Canterbury Christ Church, Edinburgh, Kent, Queen Mary University of London, and University of the Arts London. Margaret was on the Board of the Equality Challenge Unit for six years and is a member of the Athena Swan Governance Committee and was, until very recently, the Chair of Universities Human Resources supporting the development of HR professionals across the HE sector.
Additional panel members can be added upon the request of the Chair at any time during the review process, including with expertise in communications. Panel members are appointed in their personal capacities. They will assist Mr Beer in examining the evidence and developing findings and recommendations, drawing on their professional expertise and experience.
Mr Beer will be responsible for determining the Review's methodology, lines of inquiry, findings, conclusions and recommendations. Neither the University Council, the General Board, the Vice-Chancellor nor any other University officer may direct Mr Beer or the Panel as to the conduct of the Review or its conclusions.
Mr Beer will be supported by a junior barrister and a team led by Charlotte Harpin at DAC Beachcroft solicitors.
Any person who wishes to provide evidence or information relating to Part Two of the Review can do so by emailing Mr Beer and his team directly at: ArdayReviewPartTwo@dacbeachcroft.com
Jason Beer KC appointed to lead Part 2 of Independent Review following the death of Prof Jason Arday Jason Beer KC YesPhysicists knock at the door of the zeptoverse
The team, working at the upgraded LHCb experiment at CERN’s Large Hadron Collider (LHC) near Geneva, were studying beauty quarks, exotic cousins of the up and down quarks that make up all atomic matter in the universe.
When these beauty particles are created, they live for just one and a half trillionths of a second before they decay. The way they decay can tell us about physics that happens at very short distance scales: trillionths of billionths of a metre.
“What we found in these latest results is an incredibly rare decay of one of these beauty particles, where it turns into two even smaller particles called muons,” said Dr Harry Cliff from the University of Cambridge’s Cavendish Laboratory, who led the analysis team. “This process only happens for one in every ten billion beauty particles, so it’s incredibly difficult to find.”
This is the first time that evidence for this rare type of decay, known as ‘Bd to mu mu’, has been achieved by a single experiment. The results, which have not yet been peer-reviewed, will be presented today (3 November) at CERN.
Cambridge’s Cavendish Laboratory is where the first subatomic particle – the electron – was discovered in 1897, and where the neutron was discovered in 1932. But at the LHC, physicists are now probing distances 10 billion times smaller than an atom.
The LHC is powerful enough to study the structure of reality down to a hundred zeptometres – thousands of trillions of times smaller than the width of a human hair – in search of new particles that may reside in the zeptoverse. The fact that LHC has not yet seen new particles suggests they may be hiding at even shorter distances, as short as a zeptometre: a trillionth of a billionth of a metre.
The research team, which included around 20 physicists from the UK, Germany, Italy, Spain and the Netherlands, used the LHCb experiment to zoom in even further than the LHC can resolve directly. The LHCb experiment was set up to study beauty quarks, which don’t normally exist in nature but are made in huge quantities in high-energy collisions at the LHC.
By making precise measurements of the different ways beauty quarks decay, physicists can detect the quantum mechanical influence of new particles that may be far too small to see at the LHC.
In general, the rarer a decay, the more sensitive it is to the influence of new particles. Among the rarest is when a beauty quark annihilates with an oppositely charged antiquark to produce a muon and an antimuon. In the Standard Model of particle physics, this process occurs through a complicated set of interactions, making the decay extraordinarily unlikely: less than a few times per billion beauty particles.
However, in the zeptoverse, new particles could provide an additional route for the decay to follow, altering how often it occurs. For decades, these decays have been seen as ‘golden channels’ in the search for new physics. “Physicists have been looking for this rare type of decay since 1984, which was before I was born,” said Cliff.
In 2024, a major upgrade to the LHCb experiment made it possible that this rarest of decays – the Bd to mu mu decay – might be found at last. An enormous new sample of beauty decays from 2024 and 2025 harnessed the ability of the upgraded LHCb experiment to tell different types of particles apart. By using machine learning techniques, the researchers were able to suppress the huge amounts of background noise that would otherwise bury these very rare signals, allowing them to obtain the first evidence for the Bd to mu mu decay.
By combining the 2024 and 2025 data with earlier data collected between 2011 and 2018, the strength of the signal rose to 3.2 sigma, above the ‘three sigma’ level of statistical significance, the accepted evidence threshold for a new phenomenon.
“Seeing clear evidence for this rarest decay for the first time was thrilling,” said Cliff. “We’re knocking on the door of the zeptoverse now. I can’t wait to see what we find as we explore deeper.”
The new results agree with the predictions of the Standard Model, giving physicists information about which particles could be found when the LHC’s successor comes online in the second half of this century. Another major upgrade, planned for the middle of the 2030s, could increase the rate of data collection by another order of magnitude, turning these discoveries into precision probes to search for undiscovered particles, giving physicists new opportunities to find cracks in the Standard Model and reveal what may lie beyond.
Professor Tim Gershon from the University of Warwick, who leads the LHCb experiment, said: “This fantastic result showcases the extraordinary capabilities of LHCb to probe nature at the fundamental level. This project, driven and led by UK physicists, is producing beautiful science. My focus is now on delivering the upgrade of LHCb planned for the 2030s, which will be essential if we are to continue on this journey of discovery.”
The UK’s contribution to CERN is supported by the Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI).
Reference:
LHCb collaboration. ‘Evidence for the decay B0 → μ+μ− and improved measurements of B0s → μ+μ−.’
Comets didn’t seed life on Earth after all, new study suggests
The theory that comets delivered the molecular building blocks for life on Earth is a long-standing one, since comets are known to carry many of these molecules. However, a new study challenges this idea.
The researchers, led by the University of Cambridge, found the cometary delivery of these building blocks would be – at best – a ‘one-off fluke’, and not the steady rain of prebiotic molecules that had been theorised.
Using computer modelling, the researchers determined that comets travel too fast and at too sharp an angle to Earth’s atmosphere for the fragile organic molecules to survive: they would almost certainly vaporise on impact with the surface. However, the researchers also found that another planet in our system – Mars – could be a slightly more promising candidate for cometary delivery of prebiotic molecules, although this is still highly unlikely. The results are published in the journal Scientific Reports.
“Historically, scientists thought that comets were important for the origin of life on Earth, because they carried carbon- and nitrogen-bearing molecules, so these giant space snowballs were almost like a ‘get out of jail free card’ that brought all the molecules a planet would need to seed life,” said lead author Dr Richard Anslow from Cambridge’s Institute of Astronomy. “It’s kind of a romantic idea, but our results suggest it’s highly unlikely.”
In 2023, Anslow and several of his co-authors on the current paper theorised that in systems where planets orbit closely together, comets might slow down by ‘bouncing’ from one planet to the next, delivering organic molecules as they went.
Building on the earlier study, Anslow and his colleagues investigated whether such a scenario might be possible in our own Solar System. “We’re learning more and more all the time about how our Solar System and the Earth formed, and pulling this together with lots of different advances in modelling, which allowed us to investigate this idea that has been around for close to a century,” he said.
However, the new study shows just how rare that scenario is. The researchers used recent advances in comet impact simulations, comet-atmosphere interactions, and dynamic modelling of the origin and evolution of comets, to conduct their study. Taken together, the researchers found that the while the successful delivery of prebiotic molecules cannot be ruled out completely, it would be extremely unlikely.
For their study, the researchers focused on hydrogen cyanide (HCN), an important prebiotic molecule that is regularly found on Solar System comets. Their simulations showed that even in the rare event that HCN molecules survived impact with Earth, impacts delivering a useful concentration were extremely uncommon.
The number of comets hitting the Earth declined rapidly in our planet’s first 500 million years, and there were, at most, a handful of opportunities in Earth’s early history for HCN delivery on a comet. Even if HCN carried on a comet made it to the Earth’s surface, it would not have stayed concentrated for long, meaning that any prebiotic chemistry would have needed to progress very quickly from impact, which the researchers say is highly unlikely.
“It would really have to be a one-in-a-million occurrence, because not only would you need an impact at just the right speed and just the right angle, you would also need everything to happen after that point, in terms of the concentration and the speed at which the chemical origins of life got going,” said Anslow. “We can’t rule out for certain that it happened that way. But it seems to be a really rare occurrence – at best, a one-off fluke.”
So where did the molecular seeds of life on Earth come from? The researchers say there are several possibilities, including the synthesis of these molecules following the impact of asteroids, which hit the Earth far more frequently than comets. Or the chemical precursors formed from processes that occurred on Earth itself, without any outside interference.
Although cometary delivery of HCN and other prebiotic molecules to Earth seems highly unlikely, the researchers found that one of our closest neighbours could be a better candidate. Since Mars is smaller than Earth, and currently has a much thinner atmosphere, comets would be much more likely to make it to the planet’s surface during the period of the Solar System’s development when comets were far more frequent visitors.
“This is not to say it definitely happened on Mars, of course, but suggests it would be unlikely if it happened on Earth and didn’t happen on Mars,” said Anslow. “Or the other, perhaps more likely, alternative, is that it didn’t happen on either planet.”
The researchers say their results could be useful when searching for life in other systems, especially when the successors to the James Webb Space Telescope (JWST), such as the proposed Habitable Worlds Observatory, come online. Identifying systems where ‘bouncing’ comets could exist could be one way that future astronomers could narrow their search.
The research was supported in part by the Royal Society, the Leverhulme Centre for Life in the Universe, and the Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI).
Reference:
Richard J. Anslow et al. ‘Cometary impacts an unlikely pathway towards the origins of life on Earth.’ Scientific Reports (2026). DOI: 10.1038/s41598-026-74214-y
Brazil's presidential elections linked to decades of fluctuating environmental destruction – study
A University of Cambridge-led analysis of maps made from satellite imagery covering over three decades and seven presidents shows how the winner of Brazil’s national elections since 1990 directly affected the preservation of its globally vital ecosystems.
The study reveals a rollercoaster of habitat loss rates across presidencies in the country's three largest biomes – the Amazon, Cerrado, and Atlantic Forest – from a peak of 3.62 million hectares of native vegetation vanishing annually under Itamar Franco in the nineties, to a low of just 1.21 million hectares a year under Temer a decade ago.
Researchers found that the Amazon lost an average of around 994,000 hectares annually during the first three years of Luiz Inácio ‘Lula’ da Silva's current presidency, compared with 1.4 million hectares a year under his predecessor, Jair Bolsonaro.
This represents a reduction of about 29% in the average annual area of Amazon lost under Lula’s return compared with Bolsonaro’s time in office, according to the study, published in Environmental Research Communications.
However, in the Cerrado, the vast tropical savannas of central Brazil, the trend moved in the opposite direction. Annual habitat losses averaged around 1.28 million hectares between 2023 and 2025, an increase of around 50% compared with 854,000 hectares per year under Bolsonaro, during whose presidency savanna loss accelerated.
The Cerrado, a vital source of water that feeds many of Brazil’s rivers, has seen major increases in commercial farming of crops such as soybean, as US-China trade tensions during Trump’s first term saw China pivot to Brazilian soybean.
Weaker legal protections, along with efforts to curb deforestation in the Amazon, may have pushed agricultural expansion into the Cerrado, say researchers. They warn that major soy traders’ withdrawal from a moratorium on growing soy on recently deforested land could have devastating consequences for Brazil’s natural habitats.
The study also reveals how the Atlantic Forest, which stretches along Brazil's eastern coastline but has been “highly fragmented” by centuries of farming and urbanisation, actually experienced periods of recovery rather than simply a slowdown in loss.
During Lula's first two terms, the Atlantic Forest gained an average of around 18,000 hectares of native vegetation a year. Under Rousseff, that figure rose to nearly 30,000 hectares annually. Since Rousseff left office, the Atlantic Forest has returned to net vegetation losses, although at a much smaller scale than in the Amazon or Cerrado.
It is the only one of Brazil's three major biomes to have experienced periods of net vegetation gain in the last thirty-five years.
“Brazilian presidents have dictated the fate of the country’s forests and savannas for over three decades,” said study lead author Dr Vinicius Tonetti, a Brazilian conservation biologist at the University of Cambridge’s Department of Zoology.
“We see that presidential terms characterised by strong environmental laws, satellite monitoring, and zero-deforestation agreements are clearly linked to major reductions in habitat loss,” Tonetti said. “Brazil's recent history shows just how much environmental policy matters and comes from the top.”
"Our findings also show that while deforestation in the Amazon has slowed under Lula, the loss of natural habitats across the Cerrado has remained high. Protecting one ecosystem while losing another is not a sustainable solution."
The study used land-cover maps from the MapBiomas project, derived from decades of satellite data, to track changes in the Amazon, Cerrado and Atlantic Forest between 1990 and 2025.
Across all three biomes combined, the largest average annual net loss of native vegetation occurred during the presidency of Itamar Franco, between 1993 and 1994, when approximately 3.62 million hectares disappeared each year.
Fernando Henrique Cardoso's (FHC) administration, from 1995 to 2002, recorded average annual losses of around 3.30 million hectares.
Lula's first two terms, between 2003 and 2010, marked a major turning point, with loss of natural habitat falling by some 35% to an annual average of around 2.44 million hectares. In the Amazon alone, habitat loss was around 20% lower under Lula than under FHC, with a significant slowdown in the rate of deforestation.
“During Lula's first two terms, agricultural production expanded while stronger monitoring and enforcement resulted in more habitat preservation,” said Tonetti. “Economic development and environmental protection do not have to come at the expense of each other."
Under Lula’s successor Dilma Rousseff, overall habitat loss almost halved again (a further 46% reduction) to about 1.31 million hectares a year, before reaching just 1.21 million hectares a year on average during Michel Temer's time in office.
Under Bolsonaro, however, major cuts to environment agencies, weakened enforcement, reduced environmental fines, and efforts to loosen environmental regulations coincided with a sharp loss of native vegetation across ecosystems, rising to 2.36 million hectares per year on average, almost doubling (95% increase) from the historic low of Temer’s premiership.
While Lula’s return saw deforestation in the Amazon fall significantly, the overall loss of native vegetation across Brazil’s three major biomes has declined by only around 2%, largely because of increasing vegetation loss in the Cerrado.
The collapse of the soy moratorium in the Amazon and new laws restricting Indigenous land claims are part of a worrying trend that may escalate under a new president, according to Tonetti. For example, Flávio Bolsonaro has pledged to overhaul the environmental licensing system if elected.
"Brazil has shown the world that deforestation can be dramatically reduced when there is the political will to act. But that progress is fragile. Recent changes to environmental legislation and the weakening of commitments to deforestation-free soy could undermine years of conservation gains,” said Tonetti.
“As the nation once again elects a president, the voters of Brazil need to understand just how much is at stake for some of the world’s most precious forests and ecosystems.”
The single largest gap in vegetation loss between presidents for any of the biomes was seen in the Amazon, which lost an average of 1.95 million hectares a year under Fernando Henrique Cardoso but just 614,158 hectares a year under Dilma Rousseff – an area of forest the size of Montenegro spared annually.
Brazil has shown the world that deforestation can be dramatically reduced when there is the political will to act. But that progress is fragile... Vinicius Tonetti Ricardo Lima via Getty Deforestation area in the Amazon rainforest, near Monte dourado. YesGood growth: Innovate Cambridge Summit 2026
New analysis from Cambridge Innovation Capital (CIC), published ahead of the Summit, showed the average equity raised per deal across both life sciences and deep tech has increased five-fold in the last decade, with Cambridge-based early-stage companies having raised £9.1 billion in that period.
Taking leadership in innovationProfessor Deborah Prentice, Vice-Chancellor of the University of Cambridge reflected on what makes Cambridge such a thriving innovation economy and the importance of taking a proactive and global leadership role in driving innovation that works for everyone: “There are three ways in which Cambridge takes leadership: through research excellence, by acting as one ecosystem and through our partnerships with other places and organisations.”
These themes were echoed by speakers throughout the day, including Mayor Paul Bristow, Peter Freeman (Chair of the Greater Cambridge Development Corporation) and Roland Sinker (Chair of the Inclusive Innovation and Growth Review, University of Cambridge) with a recurring focus on breakthrough research, ambitious partnerships and a shared sense of purpose across the ecosystem.
Strengthening the life sciences ecosystemFollowing GSK’s recent announcement that it will be moving its R&D headquarters to Cambridge in 2029, Chief Scientific Officer, Tony Wood spoke about the increasing need for collaboration in the life sciences and that by moving to Cambridge GSK will be able to create more opportunities to achieve breakthroughs in drug discovery and patient care.
Global ambitions for quantum computingJohn Aston, Pro-Vice-Chancellor for Research at the University of Cambridge led a discussion considering the UK’s global leadership role in spearheading the development and application of quantum computing. The University’s partnership with IonQ, which next year will bring the UK’s first commercial scale quantum computer to Cambridge, combined with the University’s research strengths in both quantum and its potential applications, underpinned by the ecosystem’s strength in supporting commercialisation, means that Cambridge is uniquely placed to play a national – and global - leadership role.
City partnerships: Manchester and CambridgeFaye Holland (Director, Cambridge x Manchester Partnership) described the increasing success of the partnership between Cambridge and Manchester in combining the regions’ complementary strengths to increase the UK’s global competitiveness. The pioneering model for this cross-city approach is now being championed by government and adopted by other city partnerships across the UK.
Keeping jobs and know-how in the UKHow to create the right conditions for start-ups to grow, scale and stay in the UK was explored, and the creation of a new task force announced by Pascal Levensohn (Chair of Cambridge Innovation Hub Global Advisory Board) to take forward a new approach (outlined in a white paper published ahead of the Summit) to keeping a company’s footprint in the UK even if it is acquired internationally.
The Summit also heard from some of Cambridge’s most successful start-ups including Nyobolt and T-Therapeutics (both of which spun out of the University with support from Cambridge Enterprise) as well as Pragmatic Semiconductors, Cambridge Aerospace and CuspAI.
Widening opportunitiesEnsuring that innovation-led growth benefits everyone who lives and works in Cambridge and the wider region was a central and recurring theme. Included, a new initiative to create more opportunities for young people in Greater Cambridge was announced at the Summit, with organisations present asked to contribute opportunities such as workplace visits, work experience and mentoring.
Accelerating the energy transitionIn a parallel session, leaders from across the Cambridge cleantech ecosystem discussed accelerating the UK's clean energy transition. Hosted by DESNZ, Innovate Cambridge and Cambridge Zero, and chaired by Professor Emily Shuckburgh, Chief Scientific Adviser at DESNZ, the session brought together experts from industry, investment, academia and government. Discussions explored the opportunities and barriers to scaling cleantech innovation and commercialisation, alongside the role that innovation clusters such as Cambridge can play in addressing national clean energy challenges.
Kathryn Chapman, CEO of Innovate Cambridge, summed up the day: "Cambridge is ranked second in the world for innovation intensity, the globally leading research and talent at the University of Cambridge underpins this intensity. When academic institutions, business leaders and government come together with a single, compelling vision for innovation - we can turn the research into jobs, investment, innovation and better quality of life for communities in our region and the UK."
Vice-Chancellor Deborah Prentice speaking at Innovate Cambridge Summit 2026 YesWomen scientists almost entirely omitted from exam boards’ compulsory learning material for UK schools
The study, which analysed the UK’s six main exam boards’ specifications across science subjects, found that out of 86 scientists mentioned at Key Stage 4 (KS4), which covers GCSE and equivalent, just one was a woman – Rosalind Franklin. And even then, Franklin – whose work on X-ray crystallography led to the discovery of the double helix structure of DNA – featured in only one specification.
The researchers – who looked at specifications for biology, chemistry, environmental science, geology, physics, and astronomy – say the analysis showed that several major scientific breakthroughs taught in UK specifications were made by women, but that these women are not explicitly included in the compulsory learning material. Instead, the onus is placed on individual teachers to highlight these achievements in the classroom.
The paper – published in the British Educational Research Journal – said: "In the UK, students enrolled on science courses learn the foundations of modern science. Many of the scientific discoveries and explanations were developed in the 1800s and early 1900s, a period when scientific and mathematical practice was largely, but not solely, dominated by men. Our findings confirm that the UK science specifications reflect this historical imbalance: although women made significant contributions to major scientific breakthroughs, this fact is rarely acknowledged."
Now, the Cambridge team – Dr Greg J Cooke, Skyla B White, and Stephanie Buttigieg, who collaborated with the IncludeHer movement – say minor, targeted, adjustments could incorporate these key contributions into existing teaching frameworks with minimal changes, including the accomplishments of Nobel Prize-winning female scientists. They say this additional content could inspire more girls to continue with STEM subjects, in particular physics and mathematics, at Key Stage 5 (KS5) – which covers A-level and equivalent – and beyond.
Despite girls typically outperforming boys in the majority of STEM subjects at KS4, physics, mathematics, and further mathematics have a significantly higher uptake at KS5 among boys, with the percentage of girls choosing to study mathematics and further mathematics now lower than it was in 2005.
The researchers say they found a “compelling” correlation between the gender representation of scientists that students are exposed to at KS4 and the STEM subjects girls go on to choose to study at KS5.
The study showed that students experience a “saturation” of male scientists in compulsory physics learning materials at KS4, and suggests this could be an influence on the much lower number of girls who continue with the subject at KS5 compared to boys. By contrast, in biology and chemistry – subjects which are slightly more popular with girls than boys at KS5 – KS4 exam specifications feature fewer mentions of individual scientists overall.
While the researchers acknowledge that women’s under-representation in STEM arises from a set of complex factors, they say such a significant change in gender disparity between KS4 and KS5 suggests this transition point may be critical for retention. Pointing to the success increased exposure to relatable STEM role models has already had in shaping students’ perceptions of who science is for, they have identified specific places within the existing exam specifications where they say women scientists’ achievements can be incorporated relatively easily.
Among their recommendations, the researchers say Rosalind Franklin should be included in all biology specifications. Marie Skłodowska-Curie – who won two Nobel Prizes, discovered polonium and radium, and coined the term “radioactivity" – should be included in discussions around atomic structure and isotopes in KS4 chemistry, and Lise Meitner – a nuclear physicist who was involved in the discovery of nuclear fission, provided the first theoretical explanation of the process, but was controversially excluded from a Nobel Prize – would be an ideal role model for inclusion in KS4 physics.
Among recommendations for KS5 exam specifications, which the study also analysed and found that only three of the 181 scientists mentioned were women – Rosalind Franklin, geologist Marie Tharp, and seismologist Inge Lehman – the researchers argue that the work of Dorothy Hodgkin, who won a Nobel Prize for using X-ray crystallography to determine the structures of important, biologically relevant proteins such as insulin, would fit naturally into the study of protein structure in KS5 biology.
Dr Greg J Cooke said: “The women we recommend for the updated science specifications have helped shape the modern world. We often find ourselves obsessing over scientific facts and outcomes rather than the human journeys and rigorous methods that produced them. It is important that students understand the iterative history of science and the context behind these discoveries to frame their knowledge when assessing the bigger picture: How did Susan Solomon help save the ozone layer? How did Lise Meitner’s work eventually lead to the dawn of the nuclear age? It is long overdue that we teach these inspiring stories about women.”
Skyla B White said: “Despite years of effort to achieve gender parity in science, it is disappointing that students in the UK can complete their science education without learning the names of the women behind the scientific discoveries they study. This matters because it is at this stage, when students begin to choose which subjects to pursue further, that the gender divide grows. It’s fantastic that students learn about the Hertzsprung–Russell diagram, for example, but it was built on the work of Annie Jump Cannon, who is not mentioned. You can’t tell one story without the other.”
Stephanie Buttigieg said: “Research has shown that relatable role models can help keep more girls in STEM by strengthening their sense of belonging in science and fostering positive attitudes towards scientific careers. When school science specifications leave out women’s names, they miss a real opportunity to help girls see a future for themselves in science and continue to reinforce the harmful stereotype that science is mainly for men.”
The team has designed an app which displays the data from the study.
They are now working on a follow-up paper, looking qualitatively at how teachers incorporate scientists’ stories into the classroom. Teachers are invited to take part in a survey that will help inform the research.
Reference
Cooke, G J; White, S B; Buttigieg, S; Lowson, N; Galaudage, S; Battisti, A; Kelsey, L, and Ross, K (2026). The absence of women’s scientific contributions in core UK pre-university science qualifications. British Educational Research Journal, 00, 1–22. https://doi.org/10.1002/berj.70279
Phil Boorman/Getty Students learning in a classroom Yes Licence type AttributionWhite paper sets out blueprint for keeping innovation in the UK
In Should I stay or should I go? A Pragmatic Path to Keeping UK Innovation at Home, Pascal Levensohn (founder of Levensohn Venture Partners LLC, Executive Chairman of Dolby Family Ventures, Chair of the Cambridge Innovation Hub Global Advisory Board and Fellow of Cambridge Judge Business School) says such a commitment can be implemented without difficult and time-consuming legislation.
He argues that the debate over world-beating firms leaving the UK has conflated two separate questions – the health of the UK’s capital markets and the robustness of its innovation ecosystem – and has therefore misdiagnosed the problem. The commercial, rather than legislative, solution he proposes is a practical approach that can keep investment and high-quality jobs in the UK while the larger capital-markets debate proceeds.
Foreign ownership is not the problem
“Foreign acquisition is not the problem – and neither is foreign ownership,” says Levensohn. “A central problem is the failure to distinguish between three different forms of migration – of ownership and financial returns, of domicile and listing venue, and of productive capability.
“Treated as a single, inevitable sequence, they obscure the opportunities for targeted intervention and invite the assumption that the first or second must lead to the third. It is the third that constitutes the avoidable national loss: a listing or an acquisition followed by the migration or erosion of substantive UK productive capability.”
The solution he proposes in the paper is that: “The UK – government, universities, founders and the investment community together – should far more forcefully seek commitments from international investors and acquirers to create jobs and maintain a meaningful UK footprint for companies born in the UK, nourished by UK taxpayer investment, and first taking root in UK soil. The fruits from the UK’s innovation orchard can be harvested – ownership can change, returns can flow abroad – without pulling up the tree.”
The paper quantifies what is at stake. Between 2015 and 2025, on average 40 UK deep-tech companies were acquired each year. If just 20 of them negotiated a binding commitment resulting in 25 net new UK-based jobs, sustained for the five-year life of the commitment, the programme would generate £312.5 million of additional gross value added a year by the fifth year and would cumulate to £2.5 billion over ten years.
Levensohn cites precedents showing the feasibility of the approach, including the undertakings Japan’s SoftBank gave when it acquired Cambridge-based chip designer Arm in 2016 – to at least double Arm’s UK headcount within five years and keep its global headquarters in Cambridge – which the Takeover Panel’s independent supervisor later verified were honoured. Arm’s subsequent 2023 Nasdaq listing illustrates that a change of listing venue is not, in itself, the loss of UK productive capability.
The paper ends with a call to action for UK leaders to convene a small, authoritative task force – drawing on founders, UK and international investors, strategic acquirers, M&A counsel, universities, public-policy experts and innovation clusters – with one mandate: to turn footprint retention into standard market practice.
“The UK can continue to celebrate the companies it creates after their jobs, laboratories, compute, and manufacturing capacity have moved elsewhere. Or it can make retention a condition of serious stewardship: a standard board question, a standard investor expectation, and a standard term of doing business with the country’s most promising technologies. The UK does not need to close itself to global capital to keep more of what it creates. It needs to ask earlier, draft better, measure honestly, and then insist that the roots remain.”
Adapted from an article first published by Cambridge Judge Business School.
“Too many businesses are born in Britain but build their futures elsewhere. We should welcome global capital and negotiate harder to keep research, skills and high-value jobs at home. This timely whitepaper offers a practical way to do both.” Professor Gishan Dissanaike, Dean of Cambridge Judge Business School YesWinter sea ice loss may be underestimated, according to ancient clues from a warmer Arctic
The results, reported in the journal Nature Geoscience, could have implications for future winter conditions in the UK and across Europe.
The retreat of Arctic sea ice in the summer months has been widely reported. However, the loss of winter sea ice has received far less attention, despite the fact that climate models disagree with each other most during the winter months.
Winter ice cover plays an outsize role in weather patterns beyond the Arctic, as it regulates the release of heat and moisture to the atmosphere. Its loss has been linked to colder winters and heavier snowfall in the UK, the rest of northern Europe, and North America. In March 2025, the Arctic recorded its lowest maximum sea ice extent since modern measurements began. That record was tied again this year.
Now, researchers from the University of Cambridge and the Centro de Investigación en Matematicas in Mexico (CIMAT) have complied the largest-ever database of a key biomarker produced by algae living in sea ice to improve winter sea ice projections. The samples were taken from ocean sediment cores dating from the mid-Holocene period, when subtle shifts in the Earth’s orbit contributed to warmer conditions and reduced sea ice cover in the Arctic, offering clues into how the region might respond to future warming.
By measuring levels of the biomarker, called IP25, alongside complementary biomarkers from organisms that live in open water, the researchers were able to estimate the extent of sea ice cover thousands of years ago.
These ancient measurements were then compared to simulations from 27 climate models of the same period. Using a type of statistical analysis called Bayesian weighting, the researchers gave different weights to models based on how well they reproduced the ancient sea ice conditions. Because the same physical processes govern sea ice across different climates, these model weights could then be applied to simulations of the recent past and future.
Taken together, the models over-predicted how much winter sea ice there should be. “When we apply the model weights to historical simulations, we completely eliminated the positive bias,” said lead author Crystal Fu, from Cambridge’s Scott Polar Research Institute. “The future projections similarly end up being lower than previous estimates, by about a million square kilometres.”
Using past climate data, known as palaeoclimate data, to make predictions about the future is challenging. “The scientific community has amassed lots of palaeoclimate records over recent decades, but it’s remained a challenge to directly link these records to future projections, since there is uncertainty at both ends,” said Fu.
The approach used by Fu and her colleagues helped reduce the range of uncertainty in their projections by as much as 85%. “By using evidence from the past, we can now produce more reliable maps of where Arctic winter sea ice is likely to disappear,” said co-author Marco Aquino-López, of CIMAT. “These give us a much clearer picture of what the Arctic might look like in the coming decades, and how much uncertainty remains.”
Although the Arctic warmed for different reasons in the mid-Holocene than today, Fu says that regardless of the cause, sea ice will respond in the same way. “It doesn’t matter if the warming is natural variation or caused by human activity: if it warms, sea ice is going to melt,” she said.
The researchers say they found hints in their study that knock-on effects could be larger than expected. Applying their revised climate model weights to precipitation projections suggests that snowfall over southeast Greenland and rainfall in the Mediterranean may also be underestimated, which could have implications for the stability of the Greenland ice sheet, and future flood risk in southern Europe.
The research was supported in part by the US National Science Foundation and the Cambridge Trust. Crystal Fu is a Member of Girton College, Cambridge.
Reference:
C.Y. Fu, M.B. Osman and M.A. Anquino-López. ‘Palaeoclimate constraints tighten future Arctic winter sea ice projections.’ Nature Geoscience (2026). DOI: 10.1038/s41561-026-02123-w
Children and young people broadly support health data research – but want safeguards
The team reviewed the existing evidence, bringing together studies that capture the views of more than 4,700 children and young people and almost 1,500 parents and carers on the use of large health datasets – ‘big data’ – in children's healthcare research.
They found that children and young people, parents and carers were broadly supportive of using health data for research where there was a clear potential benefit, including improving healthcare, advancing scientific knowledge, and supporting people with similar experiences. However, support was conditional, with participants wanting research to be carried out ethically, by trustworthy organisations, and with appropriate safeguards and transparency around how their data are used.
Large-scale health datasets, drawn from electronic health records, administrative systems, registries, and digital technologies, are transforming healthcare research, generating insights into disease patterns, treatment outcomes, and population health trends.
However, there are often concerns about data being routinely reused beyond their original purpose, for example being sold to commercial companies, and about opaque governance structures and the fact that participants are typically far removed from researchers who analyse their information.
Studies of public attitudes to health data use have found broad but conditional support for data sharing, particularly where there is perceived public benefit and trust in the organisations involved. However, much of this evidence comes from general adult populations, with less evidence specifically exploring the views of children and young people, particularly those who are underrepresented in research.
Researchers from the Department of Psychiatry at the University of Cambridge carried out a systematic review of existing evidence among children and young people, including both qualitative and quantitative evidence. This allowed them to bring together findings from different types of research and identify common themes across the evidence base. Their findings are published today in PLOS Digital Health.
The review included 17 studies involving 6,261 participants, including at least 4,710 children and young people and 1,443 parents and carers.
Although participants were broadly supportive, they wanted strong protections to ensure their information is used safely and fairly. They were concerned about the potential loss of privacy and the possibility of being identified even when data are anonymised, and about the misuse of data by organisations, particularly commercial companies.
Trust was also and important issue. Young people were generally more comfortable sharing data when it was managed by trusted public organisations such as health services, universities, or non-profit researchers. They were less comfortable when private companies were involved.
A particularly important finding was that young people wanted a greater say in decisions about their data as they grow older. Some studies suggested that young people should become increasingly involved in decisions about consent and data use as they mature, rather than having decisions made entirely by parents or institutions.
Charlotte Burdge, a PhD student at the Department Psychiatry, University of Cambridge, who led the review, said:“‘Big data’ has the potential to unlock valuable insights into health and disease, but as our review has shown, we shouldn’t take for granted that everyone will give unqualified support for their data to be used.
“Young people are generally in favour and can see the benefits, but they understandably want to ensure their data is used ethically and securely, that they have control over how it’s used, and that their views are taken seriously.”
One practical measure to build trust and transparency is to make it clearer to participants how their data are being used and governed, she says. Understanding why data are being used, who may access them, and what safeguards are in place will be important as the use of data in healthcare research continues to expand.
The findings are particularly relevant as Cambridge develops new approaches to using health data and other routinely collected data to improve children’s healthcare. Charlotte’s work contributes to Children and Adolescents Data Resource (CADRE), led by Dr Anna Moore, also from the Department of Psychiatry, which is helping to establish the digital foundations for the new Cambridge Children’s Hospital. Ensuring that children and young people and families are involved in thinking about how data are collected, linked, and used will be an important part of developing data-driven approaches that are trusted and responsive to their needs.
Charlotte added: “For research such as ours, it’s important that we work with patients and members of the public from the outset to understand any concerns they may have and find out what would be meaningful for them. This will help ensure that what we’re doing aligns with their expectation.”
The researchers emphasise that these findings should not be interpreted as representing one uniform view among all underrepresented groups. People’s experiences and perspectives are shaped by their individual circumstances, backgrounds, and previous experiences with healthcare and research.
This research was funded by UKRI Medical Research Council through the Datamind, the Office for Life Sciences and the National Institute for Health and Care Research (NIHR) Mental Health Translational Research Collaboration Mission, hosted by the NIHR Oxford Health Biomedical Research Centre. Additional support was provided by the NIHR Cambridge Biomedical Research Centre and the NIHR Applied Research Collaboration East of England.
Reference
Burdge, C et al. Perceptions, attitudes, and concerns of underrepresented groups regarding the use of big data in children and young people’s healthcare research – a systematic literature review. PLOS Digital Health; 15 Oct 2026; DOI: 10.1371/journal.pdig.0001434
‘Big data’ has the potential to unlock valuable insights into health and disease, but as our review has shown, we shouldn’t take for granted that everyone will give unqualified support for their data to be used Charlotte Burdge blue sky (Unsplash) Three friends sitting outdoors under a blue sky Yes Licence type Public DomainCambridge and AstraZeneca extend programme to support PhD students
For more than a decade, the University of Cambridge and AstraZeneca have worked together at the heart of Europe’s leading life sciences cluster. They combine the strengths of a world-leading research university and a global biopharmaceutical company, united by a shared ambition to advance science, developing the next generation of scientists who can deliver innovation to the benefit of patients and society.
This latest development builds on the partnership’s strong track record of investing in early-career scientists. Since 2015, nearly 200 University of Cambridge PhD students have taken part in collaborative educational programmes with AstraZeneca, gaining experience in both academic research and drug discovery. Their experience not only benefits their own development, but also the wider scientific community, building the skills, ideas and expertise that underpin future innovation.
Nicola White, Business Engagement Manager at the University of Cambridge, explains: “This unique programme allows students to draw on a broad range of scientific expertise, technologies and resources, helping them to understand how fundamental research can contribute to the development of potential future medicines. The benefits also extend beyond the laboratories; working across academia and industry enables students to build professional networks, develop transferable skills and gain a broader understanding of the career opportunities available to them.”
The programme in practiceThe AstraZeneca-University of Cambridge PhD Programme offers four-year fully funded PhD studentships in areas of shared scientific interest, spanning three broad research areas: innovative technology and platforms; novel biological and chemistry research and data, science and AI for drug discovery and development.
Each project is jointly supervised by principal investigators from the University of Cambridge and AstraZeneca. Students spend time in laboratories across both institutions, gaining first-hand experience of two distinct, but complementary research environments.
For Caroline Wyatt, a final-year PhD student at the University of Cambridge, the opportunity to work across industry and academic settings was an important part of choosing the programme: “I’ve been lucky to have the opportunity to do a placement at AstraZeneca during my PhD. I really appreciated the industry experience and gaining an insight into how drug discovery at the high-throughput level works, while also being able to work in an academic environment where I could carry out exploratory work with access to a variety of tools and techniques.”
Shaping the future of scienceThe value of the AstraZeneca-University of Cambridge PhD programme extends beyond individual projects. By bringing academic and industry researchers together around shared scientific challenges, the collaboration creates opportunities for knowledge, ideas and expertise to move more freely between fundamental research and drug discovery.
For students, the programme offers more than the opportunity to complete a PhD. It provides exposure to different ways of working, access to a broad scientific network and the experience needed to navigate a changing research landscape. Graduates may go on to build careers in academia, industry or beyond, contributing to scientific discovery and innovation wherever their careers take them.
Jessica Corry, CEO and Co-Founder of biotech start-up Xterna, explains how the PhD programme gave her, “valuable insight into the drug discovery process. The University played a critical role in developing my scientific interests and capabilities, while AstraZeneca introduced me to the commercial aspects of the biopharmaceutical industry.
I learned how R&D operates, how teams collaborate, and how priorities can shift within a large organisation. That experience ultimately guided my decision to focus on early-stage science which has directly informed the company I’m now building, which aims to bring external innovation to large pharmaceutical companies.”
By investing in people as well as research, AstraZeneca and the University of Cambridge are helping connect today’s scientific talent with tomorrow’s discoveries.
"The PhD programme is a great demonstration of our partnership with the University of Cambridge and our joint commitment to collaboration and to developing the next generation of talent,” says Michael Tonge, Director, Global Graduate, PhD and Placement Programmes at AstraZeneca. “Developing this talent doesn’t only benefit AstraZeneca; it also strengthens the wider innovation ecosystem in Cambridge, across the UK and beyond, helping to support scientific discovery and progress for years to come."
Scientist in AstraZeneca laboratory YesFemales with autoimmune diseases ‘less likely to be believed’ than males and face longer diagnostic delays
In an international study published today in The Lancet’s eClinicalMedicine, researchers analysed the reported diagnostic experiences of 6,607 people with autoimmune diseases. The research, led by the University of Cambridge and University of East Anglia (UEA), also found that females were more likely to face delays in getting a correct diagnosis, and hence the right treatment.
The study found that 43% of females reported that their autoimmune symptoms had previously been misattributed to a psychiatric cause, compared with 33% of males. They were also more likely to report having their symptoms misdiagnosed as being ‘psychosomatic’ – in other words, that physical symptoms were caused or worsened by psychological factors – with this reported by 34% of females compared with 22% of males.
Autoimmune diseases occur when the immune system mistakenly attacks the body’s own tissues. They include conditions such as rheumatoid arthritis, lupus and multiple sclerosis. Many autoimmune diseases are more common in females.
Diagnosis can be challenging because many autoimmune diseases initially cause symptoms such as fatigue, pain, sleep disturbance or low mood, which are common in the general population. Symptoms can also affect multiple parts of the body and change over time.
After taking account of factors including age, disease group, continent and household finances, the researchers found that females were almost 50% more likely to report having received a psychiatric misdiagnosis and nearly 75% more likely to report a psychosomatic misdiagnosis than males.
Interestingly, reports of being misdiagnosed with a different physical disease was slightly higher among males than females (48% vs 44%).
The research was co-designed with patients, charities and clinicians and uncovers important parts of the diagnostic journey that are often not recorded in medical records.
Shaista Tayabali, co-author and patient partner, said: “The differences between the sexes in misdiagnoses for people with autoimmune diseases is stark. The fact that females reported higher rates of psychiatric and psychosomatic misdiagnoses than males, yet reported lower misdiagnoses for other physical diseases, suggests that historical gender biases remain a challenging aspect of the diagnostic journey.
“Although labels such as hysteria are outdated, and fortunately rarely used nowadays, as women we still often have a harder time having our symptoms believed and therefore addressed accurately.”
The researchers also found that females reported longer periods between the onset of symptoms and receiving their diagnosis, as well as more healthcare consultations. Among males, the most frequently reported time to diagnosis was less than three months, whereas among females it was one to two years.
Dr Melanie Sloan from the Department of Public Health and Primary Care at the University of Cambridge, and Norwich Medical School, University of East Anglia said: “Patients with autoimmune diseases can present with symptoms that can initially be difficult to explain medically, and sometimes it can take months or years before a diagnosis becomes clear.
“Our findings highlight that psychological or mental health explanations can be given too soon. This is true for both sexes, but our study suggests that females may be particularly vulnerable to these types of misdiagnoses.”
The high rates of reported psychiatric, psychosomatic and alternative physical misdiagnoses among both sexes reflects the difficulty of diagnosing autoimmune diseases, especially those which have few visible signs or results that show in blood tests.
The team is calling for doctors to consider autoimmune diseases before any psychiatric or psychosomatic diagnoses are given.
Professor David D’Cruz, Consultant Rheumatologist at Guy’s Hospital, said: “This is not about saying that a psychiatric diagnosis is never correct. People can have both autoimmune and psychiatric conditions, and it is increasingly understood that psychiatric symptoms can be part of an autoimmune disease, especially in diseases like lupus which can directly affect the brain. They can also be a very natural response to living with life-changing illnesses.
“The important message is that when symptoms persist, evolve or involve multiple systems, clinicians must be open minded and consider whether there is an underlying autoimmune disease that has not yet been recognised – and to listen to patients”.
Listening to patientsUnlike studies based solely on medical records, this research focused on patients’ own accounts of their diagnostic journeys. Participants were asked about the time from symptom onset to diagnosis, the number of healthcare consultations they had, and the types of diagnoses they reported receiving before their autoimmune diagnosis.
The researchers say patient perspectives are particularly important in diseases where symptoms may not be easily visible or where there is no definite diagnostic test.
Wendy Diment, patient partner in the study, said: “Most studies use medical records, but these are very one-sided as patient’s views are very rarely recorded and we often have different views on what is causing our symptoms to our doctors. They also don’t always record when we first became unwell and the difficulties in getting our diagnosis, and they’re very unlikely to be corrected when a psychosomatic ‘in your head’ type diagnosis is then found to be wrong.”
Improving diagnosisThe researchers say clinicians may benefit from acknowledging diagnostic uncertainty, providing clear advice about when patients should seek further assessment, and revisiting previous diagnostic decisions when new symptoms or information emerge.
They also highlight the importance of continuity of care and listening carefully to patients, particularly when there is not yet a clear explanation for their symptoms.
Dr Sloan said: “Ultimately, we need to understand why these differences occur before we can design effective solutions. Our next step is exploring the experiences and voices behind these numbers and working with patients and clinicians to identify ways of reducing diagnostic delays and improving care. Listening to and valuing people’s accounts and views should always be part of research and the diagnostic process.”
The study was funded by The Lupus Trust, Vasculitis UK, Sjögren’s UK, Lupus UK and SRUK.
ReferenceSloan, M, et al. Sex and disease differences in patients’ diagnostic experiences in autoimmune diseases: an international cross-sectional study. eClinMed; 13 Oct 2026; DOI: 10.1016/j.eclinm.2026.104259
Patients with autoimmune diseases can present with symptoms that can initially be difficult to explain medically, and sometimes it can take months or years before a diagnosis becomes clear Melanie Sloan Christian Lue (Unsplash) Woman looking out to sea Yes Licence type Public DomainCambridge researchers awarded ARIA funding
The funding is part of ARIA’s Universal Fabricators Programme, a three-year, £50 million programme that will support 11 different research teams. The programme’s central bet is that proteins can act as a ‘universal fabricator’.
Professor Ronan Daly, from Cambridge’s Institute for Manufacturing, leads the ‘Protein SPARK’ project, which will use proteins like tiny Lego bricks to grow magnets without rare-earth elements and advanced electrodes for batteries that hold more charge and last longer.
The team’s ‘Droplet Lego’ method takes its inspiration from the way proteins direct biomineralisation – the process by which living organisms build hard materials like bones and teeth – and runs it on a continuous production line.
Microscopic droplets carrying the designed proteins and elements will be sprayed and printed into position, much like inkjet printing. The proteins grow, guide and shape the constituent material into nanocrystals, films and three-dimensional structures, giving the team control over both the shape and the function as the material forms.
“Magnets are all around us, from headphones and mobile phones to motors and wind turbines,” said Daly. “Almost all magnets include rare-earth materials, which are costly to extract, are a diminishing resource and lead to significant environmental challenges. Our project, which is at its heart a manufacturing project, will instead use proteins to drive growth of useful magnetic materials without using rare earth materials anywhere. We will then look at how to apply this to other products, like new batteries that charge quickly and last longer.”
In addition to Daly, the team includes Professor Michael De Volder, Professor John Durrell and Dr Sebastian Pattinson from the Department of Engineering; Professor Ljiljana Fruk from the Department of Chemical Engineering and Biotechnology; and Professor Tuomas Knowles from the Yusuf Hamied Department of Chemistry; as well as researchers from the University of Amsterdam and University of Liverpool.
Cambridge researchers are also involved in two other projects in the Universal Fabricators Programme.
Dr Shijing Sun and Dr Zuyang Ye from Cambridge’s Department of Materials Science and Metallurgy; and Professor Tuomas Knowles, Josie Forsythe, Hannah Han and Max Gao from the Yusuf Hamied Department of Chemistry, are part of the Protein Organised Engineered Materials (POEM) project, which is led by the University of Washington and also involves colleagues from the University of Leeds.
The POEM team are developing a new way to make high-performance magnets by using specially designed proteins to control how magnetic crystals grow and arrange themselves. This approach could produce more powerful and reliable magnets for future technologies by giving scientists precise control over the crystals’ size, shape and spacing.
“Using proteins as templates to assemble inorganic materials could open up new processes for making a next generation of rare-earth-free magnets,” said Sun. “Our team in Cambridge brings high-throughput methods to that search, so that protein design, materials chemistry and automated experimentation work together as one.”
Professor Erwin Reisner from the Yusuf Hamied Department of Chemistry is part of the S-LATTICE project, led by the University of Edinburgh. The S-LATTICE team are developing new materials by combining naturally self-assembling proteins with metals, creating large, highly ordered sheets that can be customised with properties not found in nature. These materials could be used for precise filtration, converting carbon dioxide into useful products, cleaner catalysis, and technologies that interact with light, all within a single platform.
The Universal Fabricators Programme is led by Ivan Jayapurna.
MR.Cole_Photographer via Getty Images Abstract background YesRise of collagen-eating microbes may help explain gaps in the fossil record
The researchers, led by the University of Cambridge, say that the reason may lie in the evolution of microscopic organisms capable of breaking down collagen, a structural protein found in animal tissue.
The fossil record of animal life on Earth is highly incomplete. Hard body parts like shells, bones and teeth are far more likely to be preserved than soft body parts like muscles, organs and skin, so the majority of the fossils we have today are mineralised skeletons.
However, fossils from the late Ediacaran Period, between 579 and 539 million years ago, are different. Fossils from this time, which include the oldest known complex forms of animal life, are frequently preserved in extraordinary detail, even though none of these earliest animals had any hard body parts. In some sites, entire Ediacaran ecosystems are preserved, providing a rich window into early animal evolution.
For decades, researchers have debated how such common preservation of soft tissues was possible. Possibilities included unusual chemical conditions in the Ediacaran oceans, different tissue compositions, or the influence of a layer of microbial slime that covered the entire seafloor. However, while these explanations work in some places, none of them works everywhere.
But now, the Cambridge-led researchers say the answer may be the evolution of microbes that produce collagen-eating enzymes known as collagenases. Their results are reported in the journal Current Biology.
Collagen provides strength and support to animal tissues throughout the body. Once an organism dies, collagenases can rapidly break these tissues down, reducing the chances that they will be preserved long enough to fossilise.
“If you think about a modern jellyfish, for example, if it washes up on a beach and is left to decay, it will decompose in a matter of days,” said lead author Philip Vixseboxse, who completed the work while a PhD candidate at Cambridge’s Department of Earth Sciences. “It will never become a fossil, but similarly squishy animals from half a billion years ago did commonly get preserved.”
Collagen is in all animal tissue, but without any enzymes to break it down, it will persist, like modern plastic. “You need an enzyme to break down a biopolymer, or else it will sit around for ages until something comes along that can actually eat it,” said Vixseboxse.
Vixseboxse and his co-authors traced the evolution of collagenase genes in microbial organisms through 700 bacterial genomes, and compared them to a time-dated tree of life, to understand how microbes acquired the ability to break down collagen through time.
The researchers found that collagenases are much older than animals. Initially, they existed only in anaerobic, or oxygen-intolerant, microbes. Dead organisms in the oxygenated waters of the Ediacaran would therefore have held on to their collagen until the oxygen in the sediments surrounding them was used up, giving the organisms much more time to fossilise.
Around the transition between the Ediacaran Period and the Cambrian Period, however, collagenases began to spread among a greater range of microbial groups. They transferred into aerobic, or oxygen-using, bacteria, including the groups that cause modern decay. This shift coincides with a significant fall in the number of fossils of soft-bodied animals.
“Around this critical time when these soft-bodied animals stopped fossilising, we start seeing the appearance of collagenases in aerobic bacteria, meaning the ability to break down collagen-bearing tissues could start to spread into new environments as animal diversity accelerated,” said Vixseboxse. “Now that collagen could be degraded, you needed ever-faster fossilisation processes to outpace decay, which is likely why we start to see a big drop in the abundance and quality of the fossil record, in terms of the preservation of soft tissue.”
In some exceptional circumstances, soft tissues can be preserved in younger rocks, depending on how and where the animal died, and what happened after that. A dead animal buried beneath an avalanche of sediment soon after death, for instance, could be well-preserved and avoid decay, but these instances are rare.
“These results suggest there may be an overarching biological mechanism that has shaped the fossil record of soft tissues across Earth’s history,” said co-author Professor Alex Liu, also in the Cambridge Department of Earth Sciences. “The acquisition of key enzymes by microbes to exploit a growing food resource may have decreased the preservation potential of soft tissues.”
Vixseboxse says in the far future, there may be similar echoes with modern plastic. Like ancient collagen, plastic fails to decay until there is something that can break it down. “Bacteria had no reason to efficiently degrade collagen when it didn’t exist,” said Vixseboxse. “But once collagen became more abundant, and provided a new food source for these microbes, collagenases proliferated. Perhaps someday, microbes will exploit similar enzymes to break down the increasing abundance of plastic polymers we are putting into the environment, but that will be long after we’re gone.”
The research was supported in part by the Leverhulme Trust, the Natural Environment Research Council (NERC), and the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI).
Reference:
Philip B. Vixseboxse et al. ‘Temporal heterogeneity in the animal fossil record driven by proliferation of microbial collagenases.’ Current Biology (2026). DOI: 10.1016/j.cub.2026.09.045
Genetic analysis of the world's oldest land animal reveals secret of living 194 years
In a study published today in the journal Science Advances, scientists have pinpointed 287 unique gene variants in this remarkably old giant tortoise that reduce the usual effects of ageing. These control key processes in the body including repair of DNA damage, reducing inflammation, regulating insulin, and suppressing cancer.
Jonathan, an Aldabra giant tortoise (Aldabrachelys gigantea), is estimated to be 194 years old. This makes him the oldest living giant tortoise, and oldest land animal, in the world today. He’s thought to have hatched in 1832 - making him a contemporary of Charles Darwin and Queen Victoria.
The team also compared the giant tortoise’s epigenome - the ‘on/ off’ switches on his genes - with those of younger giant tortoises of the same species. Remarkably, they found the switches controlling Jonathan’s DNA repair and metabolism genes were very similar to those in his younger relatives. Usually, the epigenome changes over time, contributing to the ageing process - this is a key reason why things start to go wrong in older bodies.
This study marks the first time the epigenome of a giant tortoise has been investigated. It was led by researchers at longevity research non-profit Kallel in the US, who say that cracking the genetic code of a multi-century life offers unprecedented insights into extreme lifespan.
“We found that the gene regulators involved in energy production and DNA repair have remained incredibly stable in Jonathan over almost two centuries,” said Dr Justin Gerlach at Peterhouse at the University of Cambridge, who was involved in the study.
He added: “There are few creatures that could tell us more about ageing than the giant tortoises of the Galapagos and Seychelles islands. Working with a really old giant tortoise is such a privilege: you get a sense of the tortoise being your collaborator, not your study subject.”
Gerlach has studied the ecology and conservation of giant tortoises for several decades, but this is the first time he has studied their exceptionally long lives.
"Nature has already solved the puzzle of aging in remarkable ways, and Jonathan’s genome provides a blueprint for cellular resilience," said Stephen Clark MD, PhD, founder of Kallel and senior author of the study.
He added: "Our goal is to take these evolutionary insights and immediately translate them into practical, affordable treatments for everyday people. Aging is the greatest risk factor for nearly every chronic disease we face, and through the generosity of philanthropic partners, we can democratise access to longevity medicine."
Jonathan (left) arrived in St Helena in 1882. Photographer: A.L.Innes.
Jonathan has lived most of his life on the island of St Helena, a British Overseas Territory in the South Atlantic Ocean, in grounds of Plantation House - the residence of the governor of St Helena. He arrived from the Seychelles 144 years ago, already fully grown, as a gift to the governor.
The giant tortoises of the Galapagos and Seychelles islands are the extraordinary last survivors of animals that used to dominate the ecology of many of the world's islands.
The research was funded by the Voland Fund.
ReferenceVaisvil, B. et al: Epigenetic insights into extreme longevity in the world’s oldest terrestrial animal, Jonathan. Science Advances, Oct 2026. DOI: 10.1126/sciadv.adw8887
We found that the gene regulators involved in energy production and DNA repair have remained incredibly stable in Jonathan over almost two centuries. Justin Gerlach St Helena Government Communications Hub Jonathan the tortoise Yes Licence type Attribution-Noncommerical


